| Josep Malvehy; Brigitte Dreno; Enric Barba; Thomas Dirschka; Emilio Fumero; Christian Greis; Girish Gupta; Francesco Lacarrubba; Giuseppe Micali; David Moreno; Giovanni Pellacani; Laura Sampietro-Colom; Alexander Stratigos; Susanna Puig |
Introduction: Melanoma is the deadliest of all the skin cancers and its incidence is increasing every year in Europe. Patients with melanoma often present late to the specialist and treatment is delayed for many reasons (delay in patient consultation, misdiagnosis by general practitioners, and/or limited access to dermatologists). Beyond this, there are significant inequalities in skin cancer between population groups within the same country and between countries across Europe. The emergence of the COVID-19 pandemic only aggravated these health deficiencies.
